126 related articles for article (PubMed ID: 37181234)
1. KIF11 is a potential prognostic biomarker and therapeutic target for adrenocortical carcinoma.
Zhou Y; Chen X; Li B; Li Y; Zhang B
Transl Androl Urol; 2023 Apr; 12(4):594-611. PubMed ID: 37181234
[TBL] [Abstract][Full Text] [Related]
2. Kinesin family member 11 is a potential therapeutic target and is suppressed by microRNA-30a in breast cancer.
Wang B; Yu J; Sun Z; Luh F; Lin D; Shen Y; Wang T; Zhang Q; Liu X
Mol Carcinog; 2020 Aug; 59(8):908-922. PubMed ID: 32346924
[TBL] [Abstract][Full Text] [Related]
3. High expression of GMNN predicts malignant progression and poor prognosis in ACC.
Zhao X; Zhang X; Shao S; Yang Q; Shen C; Yang X; Jiao W; Liu J; Wang Y
Eur J Med Res; 2022 Dec; 27(1):301. PubMed ID: 36539849
[TBL] [Abstract][Full Text] [Related]
4. High kinesin family member 11 expression predicts poor prognosis in patients with clear cell renal cell carcinoma.
Jin Q; Dai Y; Wang Y; Zhang S; Liu G
J Clin Pathol; 2019 May; 72(5):354-362. PubMed ID: 30819726
[TBL] [Abstract][Full Text] [Related]
5. Identification of a chromatin regulator signature and potential prognostic ability for adrenocortical carcinoma.
Li J; Jia Y; Tang L; Zhang R; Zhang Y
Front Genet; 2022; 13():948353. PubMed ID: 36092868
[No Abstract] [Full Text] [Related]
6. High KIF11 expression is associated with poor outcome of NSCLC.
Liu J; Tian Y; Yi L; Gao Z; Lou M; Yuan K
Tumori; 2022 Feb; 108(1):40-46. PubMed ID: 33554761
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
Shen C; Liu J; Yang X; Jiao W; Wang Y
Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of ferroportin1 and ceruloplasmin predicts poor prognosis in adrenocortical carcinoma.
Zhu B; Zhi Q; Xie Q; Wu X; Gao Y; Chen X; Shi L
J Trace Elem Med Biol; 2019 Dec; 56():52-59. PubMed ID: 31442954
[TBL] [Abstract][Full Text] [Related]
9. High TNFSF13B expression as a predictor of poor prognosis in adrenocortical carcinoma.
Mao Y; Alimu P; Wang C; Ma W; Zhuo R; Sun F
Transl Androl Urol; 2021 Aug; 10(8):3275-3285. PubMed ID: 34532252
[TBL] [Abstract][Full Text] [Related]
10. Pan-Cancer Analysis Reveals CENPI as a Potential Biomarker and Therapeutic Target in Adrenocortical Carcinoma.
Wu F; Li G; Shen H; Huang J; Liu Z; Zhu Y; Zhong Q; Ou R; Zhang Q; Liu S
J Inflamm Res; 2023; 16():2907-2928. PubMed ID: 37465344
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
[TBL] [Abstract][Full Text] [Related]
12. KIF11: A potential prognostic biomarker for predicting bone metastasis-free survival of prostate cancer.
Wang H; Li S; Liu B; Wei S; Wang T; Li T; Lin J; Ni X
Oncol Lett; 2022 Sep; 24(3):312. PubMed ID: 35949593
[TBL] [Abstract][Full Text] [Related]
13. Identification of Five Genes as a Potential Biomarker for Predicting Progress and Prognosis in Adrenocortical Carcinoma.
Xiao H; Xu D; Chen P; Zeng G; Wang X; Zhang X
J Cancer; 2018; 9(23):4484-4495. PubMed ID: 30519354
[TBL] [Abstract][Full Text] [Related]
14. Kinesin family member 11 promotes progression of hepatocellular carcinoma via the OCT4 pathway.
Zhang J; Wei Z; Qi X; Jiang Y; Liu D; Liu K
Funct Integr Genomics; 2023 Aug; 23(3):284. PubMed ID: 37648881
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors of Adrenocortical Carcinoma: Experience from a Regional Medical Center in Eastern China.
Li P; Su X; Zhang X; Sun L; Zhang G
Int J Gen Med; 2023; 16():453-465. PubMed ID: 36760685
[TBL] [Abstract][Full Text] [Related]
16. CENPF/CDK1 signaling pathway enhances the progression of adrenocortical carcinoma by regulating the G2/M-phase cell cycle.
Huang YG; Li D; Wang L; Su XM; Tang XB
J Transl Med; 2022 Feb; 20(1):78. PubMed ID: 35123514
[TBL] [Abstract][Full Text] [Related]
17. Construction of a risk signature for adrenocortical carcinoma using immune-related genes.
Fu Y; Sun S; Bi J; Kong C
Transl Androl Urol; 2020 Oct; 9(5):1920-1930. PubMed ID: 33209656
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma.
Fu Y; Sun S; Bi J; Kong C; Yin L
Medicine (Baltimore); 2021 Mar; 100(10):e25031. PubMed ID: 33725886
[TBL] [Abstract][Full Text] [Related]
19. Characterization of KIF11 as a novel prognostic biomarker and therapeutic target for oral cancer.
Daigo K; Takano A; Thang PM; Yoshitake Y; Shinohara M; Tohnai I; Murakami Y; Maegawa J; Daigo Y
Int J Oncol; 2018 Jan; 52(1):155-165. PubMed ID: 29115586
[TBL] [Abstract][Full Text] [Related]
20. Expression of glucocorticoid receptor (GR) and clinical significance in adrenocortical carcinoma.
Wu K; Liu Z; Liang J; Zhang F; Zhang F; Wang Y; Lia T; Liu S; Zhu Y; Li X
Front Endocrinol (Lausanne); 2022; 13():903824. PubMed ID: 35992138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
